Basic/Clinical Science Session

Cytoprotection: New Guardians of the Kidneys Coming to the Fore

November 09, 2019 | 02:00 PM - 04:00 PM

Location: Ballroom B, Walter E. Washington Convention Center

Session Description

AKI results from the interplay of cytotoxic and cytoprotective mechanisms. Understanding the basis for cytoprotection, and what types and settings of AKI wherein cytoprotection is conferred, is especially important because it enables the development of therapeutic strategies in AKI. This session highlights three newly recognized cytoprotectants against AKI and underscores the role of sex and age as determinants of resistance and sensitivity to AKI.

Learning Objective(s)

  • Describe the basis for cytoprotection against AKI
  • Discuss the therapeutic significance for cytoprotection against AKI

Learning Pathway(s)

  • Acute Kidney Injury


  • Leslie S. Gewin, MD
  • Pinelopi P. Kapitsinou, MD


  • A Hybrid Cytokine for the Repair of Renal Injury
    02:00 PM - 02:30 PM
    Rahul Sharma, MS, PhD
  • The Role of Isocitrate Dehydrogenase
    02:30 PM - 03:00 PM
    Robert L. Bacallao, MD
  • The Role of S-Nitroso-CoA Reductase
    03:00 PM - 03:30 PM
    Jonathan S. Stamler, MD
  • The Role of Sex- and Age-Dependent Nephroprotection
    03:30 PM - 04:00 PM
    Lisa M. Curtis, PhD